Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
IMMP:NASDAQ
Immutep Ltd - ADR
US$ 0.57
+0.37%
(+0.0021) Siku 1
US$ 0.58
+1.22% (+0.0070)
Baada ya saa
Imefungwa: 24 Apr, 16:00:00 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya IMMP...
Fungua
US$ 0.56
Juu
US$ 0.58
Chini
US$ 0.56
Mtaji wa soko
73.53M
Wastani wa kiasi cha mauzo
28.73M
Kiasi cha mauzo ya hisa
1.89M
Juu kwa wiki 52
US$ 3.53
Chini kwa wiki 52
US$ 0.29
EPS
-US$ 0.41
Beta
2.20
Hisa za wawekezaji
147.37M
Idadi ya wafanyakazi
19
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech. Prima currently has three main products in its pipeline, all acquired with Immutep: Eftilagimod alpha, which is recombinant soluble LAG-3, used as an activator of antigen presenting cells. This product has completed a Phase IIa clinical study, where it doubled the expected response rate in HER2-negative metastatic breast cancer. IMP731, a depleting monoclonal antibody for autoimmune diseases, targeting LAG-3+ activated T cells. This antibody has been licensed to GlaxoSmithKline. IMP701, an antagonist monoclonal antibody to LAG3 for use in cancer. This product has been licensed to Novartis. Wikipedia
Kuhusu Immutep Ltd - ADR
Afisa Mkuu Mtendaji (CEO)Marc Voigt
Wafanyakazi19
Lilianzishwa2001
Makao makuu-
Sekta-
Tovutiimmutep.com
Ripoti za awaliThamani zote katika AUD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika AUD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
elfu 948.05
elfu 948.05
3.01M
3.01M
Gharama ya bidhaa zilizouzwa
18.04M
18.04M
23.31M
23.31M
Gharama ya mapato
18.04M
18.04M
23.31M
23.31M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
2.21M
2.21M
2.71M
2.71M
Gharama ya uendeshaji
2.21M
2.21M
2.71M
2.71M
Jumla ya gharama za uendeshaji
20.25M
20.25M
26.03M
26.03M
Mapato ya uendeshaji
-19.30M
-19.30M
-23.01M
-23.01M
Mapato mengine yasiyo ya uendeshaji
195.00
195.00
elfu -256.17
elfu -256.17
EBT ikijumuisha vipengee visivyo vya kawaida
-19.53M
-19.53M
-22.43M
-22.43M
EBT bila kujumuisha vipengee visivyo vya kawaida
-19.49M
-19.49M
-22.42M
-22.42M
Gharama ya kodi ya mapato
-
-
-
-
Kiwango cha kodi kinachotumika
-
-
-
-
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
-19.53M
-19.53M
-22.43M
-22.43M
Kiwango cha faida halisi
-2,059.84%
-2,059.84%
-744.36%
-744.36%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
1.08M
1.08M
elfu 798.85
elfu 798.85
Gharama ya riba
elfu -9.90
elfu -9.90
elfu -9.65
elfu -9.65
Jumla ya gharama halisi za riba
1.07M
1.07M
elfu 789.20
elfu 789.20
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-18.75M
-18.75M
-22.45M
-22.45M
Faida au hasara kutokana na uuzaji wa vipengee
593.00
593.00
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho